Three insights:
1. The market’s forecasted compound annual growth rate for the period is 5 percent. In 2019, the market reached $10.3 billion.
2. The market surge is attributed to advancements in minimally invasive surgery, an increase in spinal disorder cases and the release of improved bone grafting factors, according to the report.
3. Last year, thoracic and lumbar fusion devices accounted for the largest share of the spinal devices market, due to a rise in lumbar degenerative disc disease cases and new product launches.
More articles on devices:
Stryker ranks No. 8 in Fortune’s 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.